The personalized driver gene set identified for TCGA‐32‐2634 included TP53, RB1, KIT, and LAMA3, which could significantly explain the dysregulation of dysfunctional cancer hallmarks (PCC = 0.76, P = 1e‐05, Fig. 5D). The gene discussed is TP53; the disease is cancer.